TLPH FY 2022 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$20M

Net Income

$43M

EPS (Diluted)

$5.72

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$47M

Total Liabilities

$26M

Stockholders' Equity

$22M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$378,000	-100.0%
Gross Profit	-$2M	-$3M	+37.3%
Operating Income	-$20M	-$18M	-12.3%
Net Income	$43M	-$35M	+221.1%